Patent applications published 3 March 2010
Poniard Pharmaceuticals 2157864*
- Stabilised picoplatin dosage form
Poniard Pharmaceuticals 2157864*
- MC-1R, MC-2R- and/or µ opioid receptor stimulation
BASF Beauty Care Solutions France 2157966*
- Suspension formulations of insulinotropic peptides and uses thereof
Intarcia Therapeutics 2157967*
- Benefit agent containing delivery particle
Application papers 2157968*
- Method for preparing a granulated form
Laboratoires Aditec 2157969*
- Transdermal delivery devices assuring an improved release of an active principle through a Biological interface
TTI Ellebeau 2157970*
- EGFR inhibitors for treatment and diagnosis of metastatic prostate cancer
Rikshospitalet-Radiumhospitalet 2157971*
- Methods of treatment using intravenous formulations comprising temozolomide
Schering 2157972*
- A medicament comprising a carbostyril derivative and donepezil for treating Alzheimer’s disease
Otsuka Pharmaceutical; Juntendo University 2157973*
- Dose forms comprising VX-950 and their dosage regimen
Vertex Pharmaceuticals 2157974*
- Treatment for non-alcoholic steatohepatitis
Ares Trading 2157975*
- Thermal response polymer siloxanes, compsns and methods and applications related thereto
University of Massachusetts Medical School 2157976*
- Modulation of intestinal flora of HIV patients
NV Nutricia 2157977*
- MC-1 R, MC-2 R, and µ opioid receptors modulation
BASF Beauty Care Solutions France 2157978*
- Calcium channel proteins and uses thereof
Calcimedica 2157979*
- Methods for the directed expansion of epitopes for use as antibody ligands
Peptimmune 2157980*
- Ligands of HVEM for treating haematologic malignancies and autoimmune diseases
INSERM (Institut National de la Santé et de la Recherche Médicale) 2157981*
- Amino acid lipids and uses thereof
MDRNA 2157982*
- Collagen scaffold modified by covalent grafting of adhesion molecules
Schussler, Olivier; Miachlot, Robert 2157983*
- Medical blood treatment device for an extracorporeal blood treatment with electric muscle stimulation
Fresenius Medical Care Deutschland 2157984*
- Artificial kidney
Relitech 2157985*
- Flow reversing device and fluid treatment apparatus
Gambro Lundia 2157986*
- Blood processing apparatus with flared cell capture chamber
CaridianBCT 2157987*
- A novel process for the preparation of 3-amino-pentan-1,5-diol
F Hoffmann-La Roche 2158182*
- Ion channel modulators and methods of use
Vertex Pharmaceuticals 2158183*
- 4,5-dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
Solvay Pharmaceuticals 2158184*
- Method for producing difluoromethyl-substituted pyrazole compounds
BASF 2158185*
- Ionic N-containing compounds
Cognis IP Management 2158186*
- Cyclohexyl derivatives
F Hoffmann-La Roche 2158189*
- Epichlorohydrin, manufacturing process and use
Solvay (Société Anonyme) 2158191*
- Method for the production of substituted heteroaromates
Saltigo 2158193*
- Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
Sanofi-Aventis 2158194*
- 5-(aminoazacyclyl)-3-sulphonyl-LH-indazoles as 5-hydroxytryptamine-6 ligands for the treatment of CNS disorders
Wyeth 2158195*
- An improved process for preparing nevirapine
Aurobindo Pharma 2158196*
- Method for the preparation of high purity almotriptan
Zentiva 2158197*
- Novel N-(8-heteroaryltetrahydronaphthalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
AstraZeneca 2158198*
- Piperidine compounds and uses thereof
AstraZeneca 2158199*
- Novel chromen-2-one derivatives
NeuroSearch 2158200*
- Deri--vatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
Sanofi-Aventis 2158201*
- New compounds 892
AstraZeneca 2158202*
- Pyrimidinedione derivatives and use thereof
Schering 2158203*
- Heterocyclically substituted heterocyclyl carboxylic acid derivatives
Bayer CropScience 2158204*
- 3,3-spiroindolinone derivatives
F Hoffmann-La Roche 2158205*
- Substituted furopyrimidines and use thereof
Bayer Schering Pharma 2158206*
- Thiazoloiopyrimidines and their use as inhibitors as phosphatidylinositol-3 kinase
F Hofmmann-La Roche 2158207*
- Process for preparing an A2A-adenosine receptor agonist and its polymorphs
CV Therapeutics 2158208*
- Neurosteroid compounds
Bionature 2158209*
- RAGE fusion proteins
Glactica Pharmaceuticals 2158210*
- Mutated structural protein of a parvovirus
MediGene; Ludwig-Maximilians-Universität; Klinikum der Universität zu Köln 2158211*
- RHD6 and its use in modulating plant root hair development
Plant Bioscience 2158212*
- VM23 and VM24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type KV1.3) with high selectivity and decrease the in vivo DTH-responses in rats
Universidad Nacional Autonoma de Mexico 2158213*
- Glucagon analogues
Zealand Pharma 2158214*
- Crystal structures of neuropilin fragments and neuropilin-antibody complexes
Genentech 2158215*
- Splice variants of G-protein coupled receptor EP3 and uses thereof
Bayer Schering Pharmaceuticals 2158216*
- Human monoclonal antibody neutralising vascular endothelial growth factor receptor and use thereof
Korea Research Institute of Bioscience and Biotechnology 2158217*
- Polypeptides, antibody variable domains and antagonists
Domantis 2158218*
- Polypeptides, antibody variable domains and antagonists
Domantis 2158219*
- Display of binding agents
F-Star Biotechnologische Forschungs Und Entwicklungsges 2158220*
- Covalent disbodies and uses thereof
Macrogenics 2158221*
- Milk derived antigen specific antibodies, methods of preparation and uses thereof
Friesland Brands 2158222*
- High-amylose sodium carboxy-methyl starch sustained release excipient and process for preparing the same
Université de Montréal 2158223*
- High-viscosity beta-glucan products and methods of preparation
The Governors of the University of Alberta 2158224*
- Process for the partial hydrogenation of random vinyl arene-conjugated diene copolymers
Polimeri Europa 2158225*
- Method for producing an aqueous polymerisate dispersion
BASF 2158226*